Featured Stories Title PDF Version Shortening the Path to Diagnosis in Rare Disease Getting to know Nick France, an Alexion R&D Leading Voice Getting to know Chathuri Daluwatte, an Alexion R&D Leading Voice Getting to know Seng Cheng, an Alexion R&D Leading Voice Getting to know Sophia Zilber, Associate Director, Statistical Programming Getting to know Banu Sankaran, an Alexion R&D Leading Voice Driving health equity for the rare disease community Getting to Know Mary Kunjappu, an Alexion R&D Leading Voice Understanding & Overcoming the Challenges in Rare Disease Clinical Trials Getting to know Adrian Kielhorn, an Alexion R&D Leading Voice Children’s Book Series is Inspired By Patients Living with Rare Diseases Working Every Day for the Rare Disease Community Leading In Continued Innovation for Rare Diseases Leading in Tenacity, Grit and Curiosity to Deliver Rare Medicines Leading in Patient Centricity in Rare Disease R&D Leading in Rare Regulatory Pathways Leading In Rare Disease Clinical Trials Leading in Rare Diseases for 30 Years: Pioneering Complement Science Then and Now Rare Disease Day 2022: Advancing the Conversation Around Health Equity The Complexity of “Happy Veterans Day” Embedding patient-centricity | LEAP (Learn, Evolve, Activate, and deliver for Patients) AstraZeneca Expands Role in Rare Disease by Acquiring Alexion Pharmaceuticals RARE ANSWERS™: A System to Improve Patient Outcomes Alexion Participates in Milken Institute’s Future of Health Summit Committed to Patients: Ensuring Continuity in a Global Pandemic Alexion’s Commitment To Sustaining Our Planet Listening And Learning From The Rare Disease Patient